57
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Icatibant in hereditary angioedema: news and challenges

Pages 267-272 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Neelu Kalra & Timothy Craig. (2014) Icatibant for the treatment of hereditary angioedema. Expert Opinion on Orphan Drugs 2:7, pages 743-750.
Read now
Aasia Ghazi & J Andrew Grant. (2013) Hereditary angioedema: epidemiology, management, and role of icatibant. Biologics: Targets and Therapy 7, pages 103-113.
Read now

Articles from other publishers (7)

Jinying Gu, Qiuyu Wu, Qiuyue Zhang, Qidong You & Lei Wang. (2022) A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives. European Journal of Medicinal Chemistry 243, pages 114742.
Crossref
Sujata Bupp, Matthew Whittaker, Mari Lehtimaki, JuMe Park, Jessica Dement-Brown, Zhao-Hua Zhou & Steven Kozlowski. (2021) A novel murine in vivo model for acute hereditary angioedema attacks. Scientific Reports 11:1.
Crossref
Sabrina W Cole & Lisa M Lundquist. (2012) Icatibant for the Treatment of Hereditary Angioedema. Annals of Pharmacotherapy 47:1, pages 49-55.
Crossref
Crispian Scully. 2013. Oral and Maxillofacial Medicine. Oral and Maxillofacial Medicine 220 222 .
Laura C.G. de Graaff, Martijn van Essen, Eleonora M. Schipper, Henk Boom & Erik J.J. Duschek. (2012) Unnecessary surgery for acute abdomen secondary to angiotensin-converting enzyme inhibitor use. The American Journal of Emergency Medicine 30:8, pages 1607-1612.
Crossref
I Boccon-Gibod & L Bouillet. (2012) Safety and efficacy of icatibant self-administration for acute hereditary angioedema. Clinical and Experimental Immunology 168:3, pages 303-307.
Crossref
Donato Rigante. (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmunity Reviews 11:5, pages 348-356.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.